Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Major Depressive Disorder
2000
Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles
2006
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Personality predictors of academic outcomes: Big five correlates of GPA and SAT scores.
2007 Standout
The efficacy of psychological, educational, and behavioral treatment: Confirmation from meta-analysis.
1993
The Risk of Breast Cancer Associated with Dietary Lignans Differs by CYP17 Genotype in Women
2002
Estrogen receptors and human disease
2006 Standout
Dietary Intake of Phytoestrogens Is Associated with a Favorable Metabolic Cardiovascular Risk Profile in Postmenopausal U.S. Women: The Framingham Study
2002
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Intake of Dietary Phytoestrogens by Dutch Women
2002
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
A Case-Control Study of Dietary Phytoestrogens and Testicular Cancer Risk
2002
Risk of Human Ovarian Cancer Is Related to Dietary Intake of Selected Nutrients, Phytochemicals and Food Groups
2003
Intake of Dietary Phytoestrogens Is Low in Postmenopausal Women in the United States: The Framingham Study
2001
Racial/ethnic differences in survival rates in a population‐based series of men with breast carcinoma†
2002
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Obesity and cancer risk: the role of the insulin–IGF axis
2006
Leptin and cancer
2005
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Assessing Phytoestrogen Exposure in Epidemiologic Studies: Development of a Database (United States)
2000
Increased neurogenesis in a model of electroconvulsive therapy
2000
Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate Cancer
1999
The molecular biology of head and neck cancer
2010 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study
2007
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
2004
Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials
2006
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Maxims or myths of beauty? A meta-analytic and theoretical review.
2000 Standout
The biochemistry and medical significance of the flavonoids
2002 Standout
The Influence of Finasteride on the Development of Prostate Cancer
2003 Standout
The current understanding of the molecular determinants of inflammatory breast cancer metastasis
2005
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Neural consequences of enviromental enrichment
2000 Standout
Androgen Receptor Gene Alterations in Finnish Male Breast Cancer
2003
Oesophageal carcinoma
2013 Standout
Depression and Quality of Life in Older Persons: A Review
2015 Standout
Effects of Estrogen Receptor Expression and Histopathology on Annual Hazard Rates of Death from Breast Cancer
2006
Male breast cancer
2006 Standout
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women
2003
Neurobiology of Depression
2002 Standout
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle‐aged men
2007
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
2000
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Dermal Lymphatic Emboli in Inflammatory and Noninflammatory Breast Cancer: A French-Tunisian Joint Study in 337 Patients
2005
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Major Depressive Disorder
2008 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Hormones and prostate cancer: Current perspectives and future directions
2002
A stromal gene signature associated with inflammatory breast cancer
2007
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Physician Gender Effects in Medical Communication
2002 Standout
Phytoestrogen intake and prostate cancer: A case‐control study using a new database
1999
A meta-analytic test of intergroup contact theory.
2006 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Adiponectin as a growth inhibitor in prostate cancer cells
2005
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Polyphenols and disease risk in epidemiologic studies
2005 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Identification of meta-analyses
1990
Suramin Therapy for Patients With Symptomatic Hormone-Refractory Prostate Cancer: Results of a Randomized Phase III Trial Comparing Suramin Plus Hydrocortisone to Placebo Plus Hydrocortisone
2000
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Psychological testing and psychological assessment: A review of evidence and issues.
2001
Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer
2006
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Loss of annexin II heavy and light chains in prostate cancer and its precursors.
2001
Visceral Fat Accumulation as a Risk Factor for Prostate Cancer
2004
General and Abdominal Obesity and Survival among Young Women with Breast Cancer
2006
The effectiveness of the treatment of depression in the physically ill elderly
2000
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
1999
Weight Loss in Breast Cancer Patient Management
2002
Annexins: From Structure to Function
2002 Standout
The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents
2001
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.
2000
Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus
2000 Standout
A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer
2007 StandoutNobel
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Testicular Cancer Incidence in Eight Northern European Countries: Secular and Recent Trends
2004
Works of Shine Chang being referenced
Development of a database for assessing dietary phytoestrogen intake
1999
Inflammatory breast cancer and body mass index.
1998
Suramin-Induced Decrease in Prostate-Specific Antigen Expression With No Effect on Tumor Growth in the LNCaP Model of Human Prostate Cancer
1996
Leptin and prostate cancer
2001
Inflammatory Breast Cancer Survival: The Role of Obesity and Menopausal Status at Diagnosis
2000
A Case-Control Study of Diet and Testicular Carcinoma
1999
Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis
1999
Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.
1998
Comparison of Age-Specific Incidence Rate Patterns for Different Histopathologic Types of Breast Carcinoma
2004
Efficacy of ECT: a meta-analysis
1985
Inflammatory Breast Carcinoma and Noninflammatory Locally Advanced Breast Carcinoma: Distinct Clinicopathologic Entities?
2003
Inflammatory breast carcinoma incidence and survival
1998
Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors.
2002
Inflammatory breast carcinoma incidence and survival
1998